Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results
about
Photo-activated psoralen binds the ErbB2 catalytic kinase domain, blocking ErbB2 signaling and triggering tumor cell apoptosisDNA adducts in humans as biomarkers of exposure to environmental and occupational carcinogensThe role of concomitant extracorporeal photopheresis for the treatment of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantationExtracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsThe role of concomitant extracorporeal photopheresis for the treatment of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantationExtracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsImmunotherapy of systemic sclerosisPhase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)Histometric data obtained by in vivo confocal laser scanning microscopy in patients with systemic sclerosisCutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and managementThe role of photopheresis in the treatment of graft-versus-host diseaseFormation and repair of interstrand cross-links in DNAUVA and UVB-Induced 8-Methoxypsoralen Photoadducts and a Novel Method for their Detection by Surface-Enhanced Laser Desorption Ionization Time-of-Flight Mass Spectrometry (SELDI-TOF MS)Photopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trialCutaneous T-cell lymphoma in a cardiac transplant recipientX-Ray Psoralen Activated Cancer Therapy (X-PACT)T-cell lymphomas, a challenging disease: types, treatments, and future.Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates.Induction of monocyte-to-dendritic cell maturation by extracorporeal photochemotherapy: initiation via direct platelet signaling.Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature.Psoralen and long wavelength ultraviolet radiation as an adjuvant therapy for prevention of intimal hyperplasia and constrictive remodeling after balloon dilation: a study in the rabbit iliac artery.Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies.Therapeutic apheresis: history, clinical application, and lingering uncertainties.The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indicationsMechanistic insights into extracorporeal photochemotherapy: efficient induction of monocyte-to-dendritic cell maturation.Chronic graft-versus-host disease (GVHD) in children.Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant RecipientsChronic graft-versus-host disease: is there an alternative to the conventional treatment?Cutaneous T-cell Lymphoma.Extracorporeal photochemotherapy in the treatment of severe graft-versus-host disease.Diverse cutaneous manifestations associated with a single disease.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Novel approaches to the treatment of chronic graft-versus-host disease.Extracorporeal photopheresis in chronic graft-versus-host disease.
P2860
Q21132316-BD965FEB-4C6E-4C8F-ACC5-5AB9654689A5Q23920037-0129CC75-03F6-47CE-8EA9-8880294B7F4EQ24186279-425A71D1-A738-462B-818A-128578F26AF1Q24187102-4DD2F5E8-ABCA-48AB-B2F7-9801C81B04B1Q24187108-4184927D-B7E5-4BC2-8D4A-CBBC681331F9Q24198004-96F394A6-C0FD-42FE-BD0B-2B01179F076DQ24200272-D2FF3B9D-9C8F-4890-BB29-AFFC86A4E72DQ24200282-140C501D-7D43-43CB-AAFB-9C79DF32A468Q24200648-FD13D70C-6191-4894-BE38-6B5119235FB0Q24202963-E86C70C8-3FF9-42A7-92E9-C7AACFA4608FQ24634395-9B9196DB-0D77-448C-858C-ADAFC54B8BBEQ24681480-17CB7D70-1A81-4059-9CB5-0D39587E6B4FQ24799741-60EED9BC-70D1-4D3E-A933-CCD959B2DA38Q27024076-63B9435C-6507-4C05-96CE-D980E0537C35Q28280153-1453ED72-F18A-49D8-8BC0-A5585374EC28Q28296085-D10063F5-DDA2-468D-83A3-1037ADBDBF2FQ28299965-EB6A9186-09EA-4F56-974A-7C61E6B96608Q28344648-8181C8D8-2BD3-4C3C-B584-11573587F49DQ28362526-4E71AA8D-5B78-494D-9D89-272CD109C5B7Q28553818-7EA0F280-4593-4737-BD9B-22B169E240EFQ30244553-F67404FD-2DA5-4520-A4BC-6B465F81C96BQ30252152-44CD6778-3C30-459F-A214-41A26177BEA4Q30431256-A216F5B3-D476-42C6-8C64-C5A20FE8BB79Q30587203-F196B8E0-921D-4859-BE04-51F17BB5D652Q30650570-BCE4DCE4-3A17-4ED2-ADAF-CE0CF3B82D51Q31934440-6022033C-953B-4CB6-A75D-16CCA971660BQ33179599-6A9AD38D-6508-4B8B-9F93-23D297086524Q33387254-09DDFA5F-83B9-441C-B020-79198818FEDBQ33625948-0085A9F4-EC44-4CBE-AFDE-AF939C33E29CQ33746059-7E5C252E-AE3C-4F49-AC9F-067BE33C8F93Q33821380-32DD6276-3665-4A64-92BB-4C8E7E83EE21Q33857680-72153F8C-E842-4065-92B7-A6686095BE0EQ33873997-DA85E6E7-39D9-4C15-8ED4-FC0A2D52A2F5Q33879944-8A858602-8B9B-4B69-B24A-36B8F8F4C93FQ33889220-21B0DE50-6655-44CE-80C4-27B4DED0825AQ33900618-8365B9B6-64F1-4B5E-9C48-CA2DFBB42E00Q34116799-1F3DAD4F-D791-4B20-AF3A-9F1C21DBD30EQ34122035-72805874-F2E1-45D0-B49E-3BFCF98870EEQ34232039-785EDD7B-B0AA-4D70-A61B-5097F7F3633BQ34662907-7D567266-C6B8-447B-BE88-7567C0F1AF94
P2860
Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results
description
1987 nî lūn-bûn
@nan
1987 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Treatment of cutaneous T-cell ...... motherapy. Preliminary results
@ast
Treatment of cutaneous T-cell ...... motherapy. Preliminary results
@en
Treatment of cutaneous T-cell ...... motherapy. Preliminary results
@nl
type
label
Treatment of cutaneous T-cell ...... motherapy. Preliminary results
@ast
Treatment of cutaneous T-cell ...... motherapy. Preliminary results
@en
Treatment of cutaneous T-cell ...... motherapy. Preliminary results
@nl
prefLabel
Treatment of cutaneous T-cell ...... motherapy. Preliminary results
@ast
Treatment of cutaneous T-cell ...... motherapy. Preliminary results
@en
Treatment of cutaneous T-cell ...... motherapy. Preliminary results
@nl
P2093
P3181
P1476
Treatment of cutaneous T-cell ...... motherapy. Preliminary results
@en
P2093
B Jegasothy
B Wintroub
E Vonderheid
F Gasparro
P304
P3181
P356
10.1056/NEJM198702053160603
P407
P577
1987-02-05T00:00:00Z